Pmv Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.01
| PMVP Stock | USD 1.27 0.01 0.79% |
Pmv |
Pmv Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pmv Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pmv Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pmv Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Net Loss for the year was (58.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (51.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors |
Pmv Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pmv Stock often depends not only on the future outlook of the current and potential Pmv Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pmv Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.6 M | |
| Cash And Short Term Investments | 169.5 M |
Pmv Pharmaceuticals Technical Analysis
Pmv Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Pmv Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pmv Pharmaceuticals. In general, you should focus on analyzing Pmv Stock price patterns and their correlations with different microeconomic environments and drivers.
Pmv Pharmaceuticals Predictive Forecast Models
Pmv Pharmaceuticals' time-series forecasting models is one of many Pmv Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pmv Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pmv Pharmaceuticals
Checking the ongoing alerts about Pmv Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pmv Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pmv Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Net Loss for the year was (58.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (51.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.